The rise of the sharing economy model and gig economy, empowered by mobile IT and big data, has rapidly transformed an antiquated labor market, where the average independent worker often ended up dependent on temp…
A recent Global Mobile Money Report by Nielsen (http://dtn.fm/7rflL) shows that almost half of Chinese consumers will likely use a mobile device to make payments in restaurants, bars and retail stores—a much higher number than…
Four drug candidates in the pipeline Potential sales of Alzheimer’s drugs run to billions Hyalolex heading for clinical trials India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials…
Director nominees include Liu Shu Juan, CEO of Shewn International Group and financial controller of Shanghai Shewn Wine Co. Moxian is expected to formalize joint venture agreement with Shewn International Group by end of September…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has been invited to present at the Third Annual Robins Equity Research Roundup, which is scheduled to take place September 26-27…
Provider of mobile payment tools Using social media to drive ecommerce Marketplace that links offline and online A look at Nielsen’s latest Global Mobile Money Report (http://dtn.fm/C8SXf) shows that Moxian, Inc. (NASDAQ: MOXC) is in…
IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines…
In an effort to expand more rapidly in China, Moxian, Inc. (NASDAQ: MOXC) has shifted the focus of its joint venture strategy, including the agreement with Shewn International Group of Shanghai. An excerpt of an…
More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at…
Crystal Equity Research, encouraged by new joint venture strategy, forecasts rising revenue for Moxian (http://dtn.fm/Q8Fva) Key to market growth is UnionPay’s payment module in Moxian+ app MOXC now targets larger $2-4 million businesses for Moxian+…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has divested certain non-core assets for total consideration of $2.9 million. Additionally, the company has completed the conversion of $1.4 million…
Non-bank payment processing at $1.2 trillion, with 12.8% CAGR forecast through 2021 Large bank takeovers already underway NETE operating the right business in the right sector at the right time Savvy investors always look to…
Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones.…